Durbin Scott 4
4 · VIVEVE MEDICAL, INC. · Filed Jan 6, 2022
Insider Transaction Report
Form 4
Durbin Scott
Chief Financial Officer
Transactions
- Award
Incentive Stock Option (Right to Purchase)
2022-01-04+258,000→ 258,000 totalExercise: $1.26Exp: 2032-01-03→ Common Stock (258,000 underlying)
Footnotes (1)
- [F1]The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan, as amended (the "2013 Plan") and received 258,000 incentive stock options on January 4, 2022 (the "Grant Date"). The incentive stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date.